Incoming Teva Pharm CEO Schultz to start by month end -newspaper

JERUSALEM, Oct 17 (Reuters) - Kare Schultz will start his new post as chief executive of Israel's Teva Pharmaceutical Industries by the end of October, the Calcalist financial newspaper reported on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.